Neurothera Labs Inc. (TSXV:NTLX)

Canada flag Canada · Delayed Price · Currency is CAD
0.1800
0.00 (0.00%)
At close: Jun 3, 2026
Market Cap15.28M
Revenue (ttm)1.17M -34.5%
Net Income-5.65M
EPS-0.08
Shares Out 84.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,000
Open0.1800
Previous Close0.1800
Day's Range0.1800 - 0.1800
52-Week Range0.1550 - 0.2600
Beta-0.23
Analystsn/a
Price Targetn/a
Earnings DateAug 20, 2026

About Neurothera Labs

Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer’s disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary... [Read more]

Sector Healthcare
CEO Oz Adler
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NTLX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements